National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -4 of 4         results per page
View Search Criteria | Help With Results
           
Last Modified: 12/20/2006     First Published: 2/21/2003  

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


Under 80


Other


FRE-FNCLCC-GETUG-12/0203
EU-20238, NCT00055731

Last Modified: 10/16/2006     First Published: 8/6/2006  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


Under 80


Other


SEUG-9901
BARTS-SEUK-9901, MREC-04/5/006, BARTS-P/02/203, EU-20630, NCT00363285

Last Modified: 6/19/2008     First Published: 10/21/2006  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


Not specified


Other


ICR-CTSU-CHHIP-2006-10007
ISRCTN97182923, EU-20646, NCT00392535

Last Modified: 5/13/2008     First Published: 3/7/2008  

4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Health services research, Treatment


Active


50 to 69


Other


SHEFF-PROTECT
PROTECT, ISRCTN20141297, EU-20802, SHEFF-HTA-96/20/99, NCT00632983

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov